• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CL Detect™ 快速检测试剂在诊断和脂质体两性霉素 B 治疗皮肤利什曼病中的应用:来自印度非流行地区三级医疗中心的回顾性分析。

Application of CL Detect™ rapid test for diagnosis and liposomal amphotericin B for treatment of cutaneous leishmaniasis: A retrospective analysis from a tertiary care centre in a non-endemic area in India.

机构信息

Molecular Biology Laboratory, ICMR-National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India.

Department of Dermatology & STD, Safdarjang Hospital & VMMC, New Delhi, India.

出版信息

Indian J Dermatol Venereol Leprol. 2023;90(1):78-84. doi: 10.25259/IJDVL_1017_2022.

DOI:10.25259/IJDVL_1017_2022
PMID:37609737
Abstract

Background Increasing urbanisation has led to the occurrence of cutaneous leishmaniasis (CL) in new areas, which was otherwise localised to endemic areas. Healthcare workers should be made aware of this entity to ensure clinical suspicion of CL and investigations needed to confirm CL. The article describes patients seen at a tertiary hospital in Delhi. Aims To establish the utility of the CL Detect Rapid test as a diagnostic tool and the efficacy of Liposomal Amphotericin B (LAmB) for the complete cure of CL patients. Methods Data of patients of CL (n = 16) was retrospectively analysed concerning diagnosis and treatment. Diagnosis rested on histopathology, real-time PCR, and CL Detect Rapid Test. Speciation of the parasite was based on the Internal transcribed spacer-I gene. Patients were treated with LAmB (i.v., 5 mg/kg up to three doses, five days apart). Results A positivity of 81.3% (95%CI, 54.4-96) was observed for CL Detect Rapid test in comparison with 100% (95%CI, 79.4-100.0) for real-time PCR and 43.8% (95%CI, 19.8-70.1) for microscopy/histopathological examination. L. tropica was the infective species in all cases. All the patients treated with LAmB responded to treatment, and 9/10 patients demonstrated complete regression of lesions, while one was lost to follow-up. Limitations It is a retrospective study, and the data includes only confirmed cases of CL at a single centre. Conclusion This study highlights the utility of CL Detect as a promising diagnostic tool and the efficacy of LAmB for the complete cure of CL.

摘要

背景 城市化的不断发展导致皮肤利什曼病(CL)在新地区出现,而这些新地区原本为地方性流行区。医疗保健工作者应意识到这一实体,以确保对 CL 的临床怀疑,并进行必要的调查以确诊 CL。本文描述了在德里一家三级医院就诊的患者。目的 确定 CL Detect 快速检测作为一种诊断工具的效用,以及脂质体两性霉素 B(LAmB)对完全治愈 CL 患者的疗效。方法 回顾性分析了 16 例 CL 患者的诊断和治疗数据。诊断依据为组织病理学、实时 PCR 和 CL Detect 快速检测。寄生虫的种系分类基于内部转录间隔区-I 基因。患者接受 LAmB(静脉注射,5mg/kg,最多 3 剂,每剂相隔 5 天)治疗。结果 CL Detect 快速检测的阳性率为 81.3%(95%CI,54.4-96),与实时 PCR 的 100%(95%CI,79.4-100.0)和显微镜/组织病理学检查的 43.8%(95%CI,19.8-70.1)相比具有更高的敏感性。所有病例均为 L. tropica 感染。所有接受 LAmB 治疗的患者均对治疗有反应,9/10 例患者的病变完全消退,1 例失访。局限性 这是一项回顾性研究,数据仅包括单一中心确诊的 CL 病例。结论 本研究强调了 CL Detect 作为一种有前途的诊断工具的效用,以及 LAmB 对完全治愈 CL 的疗效。

相似文献

1
Application of CL Detect™ rapid test for diagnosis and liposomal amphotericin B for treatment of cutaneous leishmaniasis: A retrospective analysis from a tertiary care centre in a non-endemic area in India.CL Detect™ 快速检测试剂在诊断和脂质体两性霉素 B 治疗皮肤利什曼病中的应用:来自印度非流行地区三级医疗中心的回顾性分析。
Indian J Dermatol Venereol Leprol. 2023;90(1):78-84. doi: 10.25259/IJDVL_1017_2022.
2
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.脂质体两性霉素 B 治疗热带利什曼原虫引起的皮肤利什曼病。
J Eur Acad Dermatol Venereol. 2011 Aug;25(8):973-7. doi: 10.1111/j.1468-3083.2010.03908.x. Epub 2010 Dec 5.
3
Clinical and epidemiological study of cutaneous leishmaniasis in two tertiary care hospitals of Jammu and Kashmir: An emerging disease in North India.在查谟和克什米尔的两家三级护理医院进行的皮肤利什曼病的临床和流行病学研究:印度北部的一种新兴疾病。
Int J Infect Dis. 2021 Feb;103:138-145. doi: 10.1016/j.ijid.2020.11.002. Epub 2020 Nov 9.
4
Treating pediatric cutaneous Leishmania tropica with systemic liposomal amphotericin B: A retrospective, single-center study.采用全身用脂质体两性霉素 B 治疗小儿皮肤利什曼原虫病:一项回顾性单中心研究。
Dermatol Ther. 2022 Jan;35(1):e15185. doi: 10.1111/dth.15185. Epub 2021 Nov 30.
5
Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis.评估脂质体两性霉素 B 和米替福新联合治疗内脏利什曼病后皮肤利什曼病的疗效和安全性。
J Infect Dis. 2020 Feb 3;221(4):608-617. doi: 10.1093/infdis/jiz486.
6
Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B.皮肤利什曼病中的局部皮肤炎症是导致脂质体两性霉素 B 药代动力学和治疗效果变化的一个因素。
Antimicrob Agents Chemother. 2018 Sep 24;62(10). doi: 10.1128/AAC.00631-18. Print 2018 Oct.
7
Monitoring of Parasite Kinetics in Indian Post-Kala-azar Dermal Leishmaniasis.印度黑热病后皮肤利什曼病中寄生虫动力学监测。
Clin Infect Dis. 2018 Jan 18;66(3):404-410. doi: 10.1093/cid/cix808.
8
Treatment of pediatric cutaneous leishmaniasis with liposomal amphotericin B.采用脂质体两性霉素 B 治疗小儿皮肤利什曼病。
Dermatol Ther. 2022 Sep;35(9):e15706. doi: 10.1111/dth.15706. Epub 2022 Jul 19.
9
[A multifocal form of cutaneous leishmaniasis caused by Leishmania infantum in an immunocompetent child treated with a short course of liposomal amphotericin B].[一名免疫功能正常的儿童因婴儿利什曼原虫感染引发多灶性皮肤利什曼病,接受了短疗程脂质体两性霉素B治疗]
Ann Dermatol Venereol. 2016 Oct;143(10):622-624. doi: 10.1016/j.annder.2016.03.025. Epub 2016 Jun 10.
10
Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome and AmBisome in murine cutaneous leishmaniasis.脂质体两性霉素 B 制剂 Fungisome 和 AmBisome 在小鼠皮肤利什曼病中的比较疗效、毒性和生物分布。
Int J Parasitol Drugs Drug Resist. 2018 Aug;8(2):223-228. doi: 10.1016/j.ijpddr.2018.04.001. Epub 2018 Apr 12.

引用本文的文献

1
Diagnostic performance of CL Detect rapid-immunochromatographic test for cutaneous leishmaniasis: a systematic review and meta-analysis.CL Detect 快速免疫层析试验诊断皮肤利什曼病的诊断性能:系统评价和荟萃分析。
Syst Rev. 2023 Dec 20;12(1):240. doi: 10.1186/s13643-023-02422-y.